Puneri Paltan qualified directly for the Pro Kabaddi League Season 10 Semi-Final after registering a massive 56-29 victory over Tamil Thalaivas in Kolkata on Sunday
The Puneri Paltan put up a masterclass to register an emphatic 56-29 victory over the Tamil Thalaivas in Kolkata on Sunday. The Pune side also booked a place in the Pro Kabaddi League Season 10 Semi-Finals through the victory.
Rajinikanth's latest release 'Lal Salaam' is now out in theatres. The film will always hold a special place in Thalaiva's life as his daughter Aishwarya has directed it.
Their star raider Narender scored an impressive 'SUPER 10', while the team skipper and star defender Sahil Gulia got a 'HIGH FIVE', as the Tamil Thalaivas moved to eighth, just two places below the playoff spots, as per a press release from PKL.
Puneri Paltan became the second team to qualify for the Pro Kabaddi League Season 10 Playoffs after registering a 30-30 tie with Dabang Delhi KC in New Delhi
Karnataka Health Minister Dinesh Gundurao has written to Railway Minister Ashwini Vaishnaw appealing to reconsider the decision to extend the Bengaluru-Kannur express train service up to Kozhikode in Kerala
Currently, the UP Yoddhas are in 11th place in the league standings with 28 points and a score difference of -47, while the Thalaivas are positioned just one place above them in the table with 40 points and a score difference of 17
" Instead, we should strive forward with the strong sentiment of "Thakarilla Keralam, Thalarilla Keralam, Thakarkkanavilla Keralathe" ("Kerala will not be shattered, Kerala will not tire, Kerala cannot be destroyed"). The Government will provide leadership in taking forward our achievements
A defence firing on all cylinders and two raiders, Rakesh (14 points) and Rohit Gulia (9 points) ensured that the collective would take a huge victory to climb to fourth on the table, as per a PKL press release.
Researchers from the University of Auckland, Amsterdam University Medical Center, and Cambridge University Hospitals have successfully treated over ten patients with CRISPR/Cas9 technology, with preliminary findings just published in a leading journal.